key: cord-0073566-yq09901m authors: Roy, Arpita; Anand, Ashutosh; Garg, Saksham; Khan, Mohd Shahnawaz; Bhasin, Sidharth; Asghar, Muhammad Nadeem; Emran, Talha Bin title: Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast Cancer date: 2022-01-06 journal: Evid Based Complement Alternat Med DOI: 10.1155/2022/7278731 sha: e71a6c43651770e6fb7757171b1719462bf9614b doc_id: 73566 cord_uid: yq09901m Cancer is recognized as one of the main causes of mortality worldwide by the World Health Organization. The high cost of currently available cancer therapy and certain limitations of current treatment make it necessary to search for novel, cost-effective, and efficient methods of cancer treatment. Therefore, in the current investigation, sixty-two compounds from five medicinal plants (Tinospora cordifolia, Ocimum tenuiflorum, Podophyllum hexandrum, Andrographis paniculata, and Beta vulgaris) and two proteins that are associated with breast cancer, i.e., HER4/ErbB4 kinase and ERα were selected. Selected compounds were screened using Lipinski's rule, which resulted in eighteen molecules being ruled out. The remaining forty-four compounds were then taken forward for docking studies followed by molecular dynamics studies of the best screened complexes. Results showed that isocolumbin, isopropylideneandrographolide, and 14-acetylandrographolide were potential lead compounds against the selected breast cancer receptors. Furthermore, in vitro studies are required to confirm the efficacy of the lead compounds. Breast cancer is a heterogeneous group of diseases that originate in the breast tissue and result in the formation of a lump or a mass in the breast. Breast cancer mostly originates from the epithelial cells lining the milk duct [1, 2] . When the tumor is small and easily treatable, no concrete symptoms are observed, therefore making early screening important. However, a major symptom is the presence of a painless lump/mass in the breast. In some cases, cancer spreads to the lymph nodes present in the underarms and can cause swelling or lumps, even though the tumor itself is not large enough to be felt by the patient. Pain in the breast, a feeling of heaviness, swelling, or redness of the skin, and spontaneous discharge from the nipples are some of the rare symptoms experienced by some patients [3] . It is the most frequent cause of cancer and cancer-related death among women worldwide. It impacts more than 2.1 million women each year. According to the World Health Organization, in 2018, more than 620 thousand women died from breast cancer worldwide. is constitutes about 15% of all cancer-related deaths among women [4] . A total of 6.9% of cancer deaths are attributed to breast cancer with 684,996 deaths in 2020. Estrogen receptor (ER) α, an ER subtype, plays a major role in the physiological development of the body [5] . e reproductive, central nervous system, skeletal, and cardiovascular systems are some of the organ systems where ERα plays an important role in the development and functioning [5] . As shown in [5] [6] [7] , ERα is widely expressed throughout the body such as in the uterus, mammary glands, male reproductive system, ovaries, spleen, kidney, and lungs among other organs. ERα is responsible for human breast cancer progression [6, 8] . Approximately 75% of breast tumors have ERα at the time of diagnosis (ER-positive breast cancer). erefore, it has been selected as a marker for prognosis during the course of therapy that a patient receives. ER-positive markers have been found to have a better prognosis than ER-negative tumors. Tamoxifen is the most widely used drug for treating cases of ER-positive breast cancer when the patient requires endocrine therapy [9] . Other selective ER modulatory drugs are toremifene and raloxifene. Aminoglutethimide and exemestane are potent aromatase inhibitors for ER [10] . HER4/ErbB4 is a member protein of the epidermal growth factor receptor (EGFR) family. Each member of the EGFR family is essential for normal development [11] in animals and humans. ey are necessary for the healthy development of the heart, nervous system, and mammary gland [11] . HER4 is known for its crucial role in carcinogenesis [12] . However, unlike other members of EGFR, HER4 signaling is less understood. It is known to play a positive role in cancer progression, especially breast cancer in humans [13, 14] . As reported by Zhu et al. [15] , HER4, alone, could moderate the estrogen-induced growth of breast cancer cells. And, as observed in vitro, overexpression of HER4 influences cell cycle arrest and apoptosis significantly in breast cancer [15, 16] . Canertinib, developed by Pfizer, inhibits HER2 and HER4, but due to its limited effect, as shown in phases I and II, this drug was discontinued [17] . Afatinib, an irreversible tyrosine kinase inhibitor, simultaneously targets HER2 and HER4 [18] . It also suppresses HER3-mediated signaling [19] . Natural compounds are one of the potential sources of bioactive compounds [20] . Plant-derived compounds possess a wide range of therapeutic actions, which include anticancer, antidiabetic, antibacterial, and antifungal activities [21] [22] [23] . e anticancer activity of various plantderived compounds has been reported in various studies [24] [25] [26] [27] [28] . is study elucidates the molecular docking and dynamic results between biochemical compounds taken from five different plants, namely, Tinospora cordifolia, Ocimum tenuiflorum, Podophyllum hexandrum, Andrographis paniculata, and Beta vulgaris, and two proteins, namely, human ERα (PDP Id: 2IOG) and HER4/ErbB4 (PDP Id: 3BBT), to propose a natural phytochemical compound which could potentially treat breast cancer. e 3D crystal structures of the proteins considered in this study were imported from the Protein Data Bank (RCSB PDB) Web server [28] . For the following study, two proteins were taken for the search of their antagonists, HER4/ErbB4 kinase (PDB ID: 3BBT) and human estrogen receptor ɑ (PBD ID: 2IOG). For the analysis and prediction of the potential ligand, a data set of 62 phytocompounds from Tinospora cordifolia, Podophyllum hexandrum, Andrographis paniculata, Beet vulgaris, and Ocimum sanctum was selected (Table 1) . e structures obtained from the PubChem database [27, 29] of all compounds were converted from .sdf format to .pdb format using the Discovery Studio Visualizer by BIOVIA. e SwissADME tool [30] by ExPASy tools was used to determine the values of parameters proposed in the Lipinski Rule of Five [31] . In addition to lipophilicity, the number of hydrogen bond donors and accepters, and molecular weight, one parameter, molar refractivity (Ghose rule), was also taken into account to test the drug-likeliness of all the 62 compounds [32] . Interaction studies of receptor structure with selected ligands were performed using the AutoDock v4.2.6 interface. e protocol started with the preparation of a receptor/protein in which surrounding water was removed from the vicinity of the protein, Kollman charges were added, and polar hydrogens were added, merging nonpolar at the same time. All the rotatable bonds of the ligand were allowed to rotate, and the Gasteiger charges were computed. Grid coordinates were selected using the existing inhibitor in the receptor after which the bound inhibitor was also removed to vacate the active site. e Lamarckian GA output was used to obtain the docking results using a genetic algorithm. Of the 10 conformations obtained, the one with the least binding energy was selected, and 2D binding interactions between active site residues and the ligand were generated using the BIOVIA Discovery Studio Visualizer v19.1.0.18287. Dynamics. 100 ns simulations of the docked receptor-ligand complex were carried out. Molecular simulations were carried out on the Desmond-Maestro module 2020. All the parameters and algorithms were kept as default. Desmond by itself uses the most efficient algorithms for generating precise output data. e TIP3P model system of water was provided to the docked complex to provide a medium. 0.15 M Na + ions were added to neutralize the whole system with OPLS-AA 2005 as the assigned force field. e SHAKE/RATTLE algorithm restricted the covalent bond movement. NVT ensemble with 300K as temperature and 1 bar as pressure, and all inputs were combined using the RESPA integrator. 100 ns simulations were allowed to be subdivided into 1000 frames for dynamic analysis of proteinligand interaction [33, 34] . 2.6. PASS Webserver. Based on the structures using multilevel neighbors of atoms description, the PASS webserver can be used to predict the biological activity of the compound. e SMILES of the compound are taken as the input, and the probability of a biological activity can be obtained as the output. 3.1. ADME Testing. A preliminary structure-based analysis was conducted on the selected 62 phytocompounds which 2 Evidence-Based Complementary and Alternative Medicine were reported in our earlier study [35] . Compounds were subjected to a total of 5 parameters: logP/lipophilicity (<5), molar refractivity (40-130), molecular weight (<500 Da), hydrogen bond acceptor (<10), and hydrogen bond donors (<5) [36, 37] . 18 small molecules showed two or more violations of parameters which resulted in their omission from further analysis. Docking. e minimum binding energy among all 3BBT-isopropylideneandrographolide complexes was −9.41 kcal/mol. A total of 16 residues interacted with the ligand molecule. THR835 and PHE837 formed strong hydrogen bonds. Another type of interaction was alkyl and van der Waals. CYS778, LEU825, ALA724, VAL707, LEU769, and LYS726 formed an alkyl bond with isopropylideneandrographolide ( Figure 1 ) ( Table 2) . Out of the 10 conformations obtained for the 3BBTisocolumbin complex, −9.06 kcal/mol was the best binding energy. Four different types of bond formation took place. THR835 and LEU 825 interacted with the five membered ring with pi-sigma interaction. ASP836 formed a conventional carbon-hydrogen bond. LYS726, VAL756, LEU758, LEU769, LEU839, and MET747 interacted by forming alkyl Figure 2 ). Figure 3 represents the best docked conformation of the 2IOG-isopropylideneandrographolide complex having a binding energy of −10.3 kcal/mol. 18 residues in total interacted with the present ligand. CYS530 and THR347 formed conventional hydrogen bonds. ASP351 was the only residue forming a carbon-hydrogen bond. 4 residues interacted with weak van der Waals forces. All the other residues either interacted with either the alkyl or pi-alkyl bond formation. e best complex with 14-actetylandrographolide showed a binding energy of −9.26 kcal/mol; cumulatively, 21 residues around the ligand interacted with it. CYS530 and MET343 acted as anchors forming strong conventional hydrogen bonds. MET421, LEU384, MET388, LEU387, PHE404, LEU525, and LEY346 formed either alkyl or pialkyl bonds. 11 residues showed weak van der Waals interactions. THR347 formed an unfavorable donor-donor bond ( Figure 4) (Table 1) . Simulation studies were carried out on the two best docked complexes for each receptor taken into account. Each dock was allowed to simulate in the dynamic environment for 100 ns seconds to yield the potential energy and total energy (Table 3) . Using four parameters, the conformational stability of the protein and ligand can be analyzed. e root mean square deviation (RMSD), root mean square fluctuations (RMSF), radius of gyration (rGyr), and solvent accessible surface area (SASA) plots can be insightful for defining the compactness of protein and ligand complexes. A stabilized RMSD plot can be observed with isocolumbin as the ligand molecule. e graph can be observed to fluctuate a little but around a fixed average value only, i.e., 2.5Å. Although during 20-40 ns a few small peaks are visible of magnitude 1Å for backbone atoms and Cɑ atoms, this sudden peak can be regarded to the internal vibrations of the atoms. After 40 ns, a stable plateau is attained, lasting throughout the simulation. With isopropylideneandrographolide as a ligand molecule, a significant deviation (>3) can be seen (>3Å) suggesting large conformational changes in the protein, which is not preferable. After 40 ns the graph stabilizes to the end around a value of 5 which is still higher compared to the RMSD of the 3BBT-isocolumbin complex ( Figure 5(a) ). RMSF graphs for both the ligand complexes can be observed as they should be. Secondary structures like the alpha-helix and beta-sheets are more rigid portions of the protein and therefore should fluctuate less, which is exactly what the RMSF plot showed. e unstructured part, including loops and straight chains of amino acids, fluctuated relatively more ( Figure 5(b) ). e rGyr plot for the isolcolumbin complex yielded a value of 3.66 ± 0.12Å. e probability distribution graph revealed Evidence-Based Complementary and Alternative Medicine that in most frames, the 3.66Å was achieved with little or no fluctuation overall. e isopropylideneandrographolide complex showed a higher rGyr value of 4.40Å with a very nominal crest and troughs. Both the graphs suggest the compactness of the complex; however, the lower value of isocolumbin gives it an edge suggesting a more compact structure during the simulation course ( Figure 5(c) ). Isocolumbin again provides a lower SASA value than the isopropylideneandrographolide; an average of 30Å SASA is observed with the isocolumbin ligand, whereas this number goes up to 100Å with the other ligand, with more variations in the overall graph. e binding of isolcolumbin with the protein is fairly more stable and the core residues are not exposed to the surrounding water, suggesting a good binding of the ligand with the 3BBT receptor ( Figure 5(d) ). Receptor ɑ (2IOG) . Toward the later stages of the dynamics, the RMSD plot with 14-acetylandrographolide stabilized almost at 3.2 without any . At the beginning, from 10 to 20 ns, a relatively higher peak can be observed, but after 20 ns, the plateau is attained. Toward the end, there was a dip in the graph as well. e observations are suggestive of protein stability with both the ligand molecules ( Figure 6(a) ). Fluctuations considering residues as the basic entity were measured using the RMSF plot. e general convention of amino acids forming secondary structures deviating less as compared to free amino acids such as loops and straight chains was quite visibly followed by both ligand complexes. e binding pocket can be said to lie somewhere in the middle of being flexible and rigid as residues of both natures interacted with the ligand (Figure 6(b) ). e rGyr plot is suggestive of the compactness of the protein structure. At 100 ns, a value of 3.8Å was obtained with the protein-14-acetylandrographolide complex, while with isopropylideneandrographolide a value of 4.2Å was obtained. e smaller value of 2IOG-14-acetylandrographolide suggests a more compact protein (Figure 6(c) ). Both the complexes averaged 10Å 2 in the SASA plot which is also confirmed by the probability distribution plot. e exposure of core residues to the surrounding solvent is minimal which is an additive property to protein stability. e formation of a hydrophobic pocket around both Evidence-Based Complementary and Alternative Medicine 7 residues also provides confirmation for the lower SASA value (Figure 6(d) ). 44.39% of amino acids of 3BBT when bound to isocolumbin took part in secondary structure formation, while with isopropylideneandrographolide the percentage reduced to 41.03% which can be targeted toward the increased SASA value. A difference of 1% can be observed in the 2IOG protein with two different ligands. With 14-acetylandrographolide, a total of 58.08% of residues formed secondary structures, while the number decreased to 57.07% with isopropylideneandrographolide (Table 4) . To assess the binding of protein-ligand complexes, protein-ligand contact estimation and analysis become crucial. Considering the 3BBT-isocolumbin complex (Figure 7(b) ), ASP836 and GLY838 anchored the ligand molecules with multiple contacts, and both formed significant string hydrogen bonds. ey are assisted by the VAL756 residue, which forms the major water bridges. A total of 25 residues interacted with the ligand at different instances. LYS726, PHE837, LEU758, and VAL756 formed multiple types of bonds. e timeline (Figure 7 (a)) interacts with 27 amino acids, but only only MET774 acts as the anchor to the ligand. e remaining amino acids interacted with the ligand in a scattered and faded manner with a lot more instances of zero contact with the ligand. Two 2IOG complexes showed quite significant interactions in their own sense. e complex with 14-acetylandrographolide had 31 total residues that interacted with it. GLU419 forms a strong hydrogen bond along with HIS524 and a few more residues. ALA350, TRP383, LEU387, MET388, LEU391, PHE404, VAL418, and LEU525 (Figure 7(c) ) stabilized the protein-ligand complex using hydrophobic interactions and contributed to the retention of the ligand in the binding pocket. On the other hand, with isopropylideneandrographolide, LEU346 formed major interactions by showing 3 types of binding, i.e., hydrogen bonds, hydrophobic bonds, and water bridges. e LEU346 interaction is briefly assisted by various residues such as ALA350, LEU383, LEU391, LEU 428, MET525, MET421, PHE404, and MET388 (Figure 7(d) ). In the beginning, a lot of instances can be observed having no contact with the ligand which may explain the higher RMSD in the beginning. In the last decade or so, virtual screening of ligand libraries has proven to be a quite effective methodology for aiding research in the therapy of various ailments. Breast GLY_702 ALA_703 DHE_704 VAL_707 TYR_708 ALA_724 ILE_725 LYS_726 VAL_756 LEU_769 LEU_773 MET_774 PRO_775 HIS_776 GLY_777 GLU_781 ARG_822 ASN_823 LEU_825 THR_835 ASP_836 CYS_778 LEU_780 THR_771 GLN_772 SER_701 LEU_699 Total count % of contacts LEU_699 GLY_700 PHE_704 VAL_707 TYR_708 ALA_724 ILE_725 LYS_726 VAL_756 LEU_758 MET_774 CYS_778 MET_747 MET_750 ARG_822 PHE_837 GLY_838 LEU_839 LEU_842 LEU_825 ILE_834 LEU_769 THR_771 THR_835 ASP_836 LEU_699 GLY_700 PHE_704 VAL_707 TYR_708 ALA_724 ILE_725 GLY_344 LEU_346 THR_347 LEU_349 ALA_350 ASP_351 TRP_383 LEU_384 LEU_387 MET_388 MET_421 MET_427 MET_517 HIS_524 ILE_424 LEU_391 LEU_428 LEU_525 MET_528 LYS_529 CYS_530 CYS_531 ASN_532 VAL_533 VAL_534 PHE_404 PHE_425 MET_343 SER_341 GLY_344 LEU_346 THR_347 LEU_349 ALA_350 ASP_351 TRP_383 LEU_384 LEU_387 MET_388 MET_421 MET_427 MET_517 HIS_524 ILE_424 LEU_391 LEU_428 LEU_525 MET_528 LYS_529 CYS_530 CYS_531 ASN_532 VAL_533 MET_342 MET_343 LEU_345 LEU_346 THR_347 ASN_348 LEU_349 LEU_384 LEU_387 MET_388 LEU_391 LEU_403 PHE_404 VAL_418 GLU_419 GLU_420 MET_421 ILE_424 LEU_428 LEU_525 SER_527 MET_528 LYS_529 VAL_533 VAL_534 GLY_521 HIS_524 ARG_394 ALA_350 GLU_353 TRP_383 MET_342 MET_343 LEU_345 LEU_346 THR_347 ASN_348 LEU_349 LEU_384 LEU_387 MET_388 LEU_391 LEU_403 PHE_404 VAL_418 GLU_419 GLU_420 MET_421 ILE_424 LEU_428 LEU_525 SER_527 MET_528 LYS_529 VAL_533 VAL_534 GLY_521 HIS_524 ARG_394 ALA_350 GLU_353 TRP_383 (d) cancer is one such ailment which predominantly affects women. Developing a lead molecule for breast cancer is important and also interesting, considering the complex molecular nature. In this investigation, the computationalbased screening defines the initial steps toward the development of a lead compound. Numerous other studies have shown the essentiality of the protein molecules taken in this study, i.e., the estrogen receptor and HER4 protein. Recently, phytochemicals have been an area of interest for all drug formulation experts, and a similar interest drove us to explore the compounds known from five plants which are under investigation for their anticancer effects. Beet vulgaris has been of interest to many researchers, and they have successfully shown its cytotoxic activities [38] against various tumors such as liver, skin, and lung tumors [38] [39] [40] [41] . Similar activity is shown by Ocimum sanctum extract against leukemic cell lines [42] , while Tinospora cordifolia is being extensively studied. It modulated multiple pathways in colon cancer to prevent its proliferation and growth [43] . Some investigations regard Andrographis paniculata as a miracle folk plant for treating cancer. Studies have concluded its extract puts a stopper to cell growth and reduces the chromosomal aberrations [44] . In certain cell lines, the extract also influenced the inflammatory pathways by inactivating NF-kB pathways [45] . Our study, coincidentally, concluded to find two potential compounds extracted from Andrographis paniculata alone and the other from Tinospora cordifolia. Our study highlights the particular compounds present in the extracts which can specifically target the breast cancer proteins. e results are even suggestive of a multitarget drug molecule, i.e., isopropylideneandrographolide. e webserver can be used to predict the biological activity based on the ligand's structure. e three shortlisted compounds in the study were subjected to the prediction. All of the compounds led to the same biological activity. e probability of the ligands acting as antineoplastics, i.e., drugs having tumor restrictive property, ranged between 0.882 and 0.959 when Pa > Pi (Table 5 ). e aim of this study was to identify natural compounds that can prove effective against different proteins associated with breast cancer with few or no side effects. Sixty-two compounds from five selected plants were shortlisted for this study, out of which eighteen compounds were ruled out in violation with Lipinski's rule of five. e least binding affinities and corresponding binding poses for the remaining forty-four compounds were determined. ereafter, MD simulation studies were carried out on the two best docked complexes for each receptor taken into account, followed by prediction of biological activity of the lead compounds. e results revealed that isocolumbin, isopropylideneandrographolide, and 14-acetylandrographolide are lead compounds against selected breast cancer proteins. All these compounds have antineoplastic effects. Further research should be encouraged to determine the in vitro efficacy of the lead compounds and their exact mechanism of action. e data used to support the findings of this study are included within the article. e authors declare that they have no conflicts of interest. Pa � probability to be active; Pi � probability to be inactive. Heterogeneity in breast cancer Antimicrobial peptides as potential therapeutic agents: a review Preventing cancer Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update. Genes & Diseases Estrogen receptor signaling during vertebrate development Estrogen receptor transcription and transactivation Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action Estrogen receptors alpha (ERα) and beta subtype-selective ligands and clinical potential e estrogen receptor family Treatment of estrogen receptor-positive breast cancer Current medical treatment of estrogen receptorpositive breast cancer NEW EMBO MEMBERS' REVIEW: the ErbB signaling network: receptor heterodimerization in development and cancer Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1 Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazolineand 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: potential impact in colorectal cancer Venom-derived bioactive compounds as potential anticancer agents: a review Molecular docking analysis of selected phytochemicals against SARS-CoV-2 Mpro receptor Medicinal plants as a potential source of chemopreventive agents Medicinal plants in the management of cancer: a review Plumbagin: a potential anti-cancer compound A review on medicinal plants against cancer Anticancer agent from medicinal plants: a review A review on pharmaceutically important medical plant: plumbago zeylanica Centella asiatica: a pharmaceutically important medicinal plant e protein data bank PubChem substance and compound databases Nostocine A derivatives as human DNA topoisomerase II-alpha inhibitor SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules Lead-and drug-like compounds: the rule-offive revolution Molecular dynamics simulation, synthesis and topoisomerase inhibitory actions of vanillin derivatives: a systematic computational structural integument User Manual Evaluation of different phytochemicals against BRCA2 receptor In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2 Molecular docking analysis of selected phytochemicals against SARS-CoV-2 Mpro receptor Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines Drinking water with red beetroot food color antagonizes esophageal carcinogenesis in N-Nitrosomethylbenzylamine-Treated rats Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot Effect of Ocimum sanctum extract on leukemic cell lines: a preliminary in-vitro study Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways Andrographia paniculata a Miracle Herbs for cancer treatment: in vivo and in vitro studies against Aflatoxin B1 Toxicity Anticancer activity of Andrographis paniculata and Silybum marianum on five human cancer cell lines MSK acknowledges the generous support from the Research Supporting Project (RSP-2021/352) by King Saud University, Riyadh, Kingdom of Saudi Arabia.